89 related articles for article (PubMed ID: 29776265)
1. Research Highlights: Highlights from the latest articles in molecular profiling and prognosis in acute myeloid leukemia.
Aljitawi OS; Lin TL
Per Med; 2012 Sep; 9(7):679-682. PubMed ID: 29776265
[No Abstract] [Full Text] [Related]
2. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling.
Verhaak RG; Wouters BJ; Erpelinck CA; Abbas S; Beverloo HB; Lugthart S; Löwenberg B; Delwel R; Valk PJ
Haematologica; 2009 Jan; 94(1):131-4. PubMed ID: 18838472
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of acute myeloid leukemia and its impact on treatment.
Frankfurt O; Licht JD; Tallman MS
Curr Opin Oncol; 2007 Nov; 19(6):635-49. PubMed ID: 17906465
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations.
Ryotokuji T; Yamaguchi H; Ueki T; Usuki K; Kurosawa S; Kobayashi Y; Kawata E; Tajika K; Gomi S; Kanda J; Kobayashi A; Omori I; Marumo A; Fujiwara Y; Yui S; Terada K; Fukunaga K; Hirakawa T; Arai K; Kitano T; Kosaka F; Tamai H; Nakayama K; Wakita S; Fukuda T; Inokuchi K
Haematologica; 2016 Sep; 101(9):1074-81. PubMed ID: 27247325
[TBL] [Abstract][Full Text] [Related]
5. Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances.
Mrózek K; Döhner H; Bloomfield CD
Curr Opin Hematol; 2007 Mar; 14(2):106-14. PubMed ID: 17255787
[TBL] [Abstract][Full Text] [Related]
6. A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.
Zhu R; Zhao W; Fan F; Tang L; Liu J; Luo T; Deng J; Hu Y
Oncotarget; 2017 Jun; 8(24):38902-38913. PubMed ID: 28473658
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of miR-99a is associated with poor prognosis of acute myeloid leukemia and promotes myeloid leukemia cell expansion.
Si X; Zhang X; Hao X; Li Y; Chen Z; Ding Y; Shi H; Bai J; Gao Y; Cheng T; Yang FC; Zhou Y
Oncotarget; 2016 Nov; 7(47):78095-78109. PubMed ID: 27801668
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling in acute myeloid leukemia.
Bullinger L
Haematologica; 2006 Jun; 91(6):733-8. PubMed ID: 16769574
[No Abstract] [Full Text] [Related]
9. Multiplex high-throughput gene mutation analysis in acute myeloid leukemia.
Dunlap J; Beadling C; Warrick A; Neff T; Fleming WH; Loriaux M; Heinrich MC; Kovacsovics T; Kelemen K; Leeborg N; Gatter K; Braziel RM; Press R; Corless CL; Fan G
Hum Pathol; 2012 Dec; 43(12):2167-76. PubMed ID: 22658276
[TBL] [Abstract][Full Text] [Related]
10. CD147 and VEGF co-expression predicts prognosis in patients with acute myeloid leukemia.
Fu J; Fu J; Chen X; Zhang Y; Gu H; Bai Y
Jpn J Clin Oncol; 2010 Nov; 40(11):1046-52. PubMed ID: 20558462
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8.
Koh Y; Kim I; Bae JY; Song EY; Kim HK; Yoon SS; Lee DS; Park SS; Park MH; Park S; Kim BK
Jpn J Clin Oncol; 2010 Nov; 40(11):1037-45. PubMed ID: 20587614
[TBL] [Abstract][Full Text] [Related]
12. Genomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid Leukemia.
Wang BH; Li YH; Yu L
Chin Med J (Engl); 2015 Sep; 128(17):2395-403. PubMed ID: 26315090
[TBL] [Abstract][Full Text] [Related]
13. Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia.
Zhou JD; Yao DM; Han L; Xiao GF; Guo H; Zhang TJ; Li XX; Yuan Q; Yang L; Lin J; Qian J
Tumour Biol; 2017 Apr; 39(4):1010428317699123. PubMed ID: 28443469
[TBL] [Abstract][Full Text] [Related]
14. Progress and strategies for patients with relapsed and refractory acute myeloid leukemia.
Litzow MR
Curr Opin Hematol; 2007 Mar; 14(2):130-7. PubMed ID: 17255790
[TBL] [Abstract][Full Text] [Related]
15. Molecular and cytogenetic abnormalities in acute myeloid leukemia: review and case studies.
Velloso ED; Motta CH; Furtado JB; Bacal NS; Silveira PA; Moyses CB; Sitnik R; Pinho JR
Einstein (Sao Paulo); 2011 Jun; 9(2):184-9. PubMed ID: 26760813
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profile related to prognosis of acute myeloid leukemia.
Park MH; Cho SA; Yoo KH; Yang MH; Ahn JY; Lee HS; Lee KE; Mun YC; Cho DH; Seong CM; Park JH
Oncol Rep; 2007 Dec; 18(6):1395-402. PubMed ID: 17982622
[TBL] [Abstract][Full Text] [Related]
17. [Progress of studies on genetics of childhood acute leukemia].
Yue ZX; Zheng HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):791-5. PubMed ID: 23815942
[TBL] [Abstract][Full Text] [Related]
18. Gene-expression profiling in acute myeloid leukemia.
Grimwade D; Haferlach T
N Engl J Med; 2004 Apr; 350(16):1676-8. PubMed ID: 15084701
[No Abstract] [Full Text] [Related]
19. Clinical relevance of circulating immune complexes in human leukemia. Association in acute leukemia of the presence of immune complexes with unfavorable prognosis.
Carpentier NA; Lange GT; Fiere DM; Fournie GJ; Lambert PH; Miescher PA
J Clin Invest; 1977 Oct; 60(4):874-84. PubMed ID: 268330
[TBL] [Abstract][Full Text] [Related]
20. Treatment of childhood acute myeloid leukemia.
ter Bals E; Kaspers GJ
Expert Rev Anticancer Ther; 2005 Oct; 5(5):917-29. PubMed ID: 16221060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]